image
Healthcare - Medical - Care Facilities - NYSE - US
$ 65.08
-3.01 %
$ 989 M
Market Cap
35.37
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one USPH stock under the worst case scenario is HIDDEN Compared to the current market price of 65.1 USD, U.S. Physical Therapy, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one USPH stock under the base case scenario is HIDDEN Compared to the current market price of 65.1 USD, U.S. Physical Therapy, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one USPH stock under the best case scenario is HIDDEN Compared to the current market price of 65.1 USD, U.S. Physical Therapy, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart USPH

image
$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.0$65.0$65.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
561 M REVENUE
-7.32%
63.2 M OPERATING INCOME
-9.12%
45.6 M NET INCOME
22.51%
74.9 M OPERATING CASH FLOW
-8.59%
-149 M INVESTING CASH FLOW
-232.00%
-37 M FINANCING CASH FLOW
-43.85%
150 M REVENUE
-10.70%
14.5 M OPERATING INCOME
-1.41%
12.5 M NET INCOME
27.79%
19.4 M OPERATING CASH FLOW
-12.26%
-94.9 M INVESTING CASH FLOW
-1523.64%
-153 K FINANCING CASH FLOW
98.75%
Balance Sheet U.S. Physical Therapy, Inc.
image
Current Assets 138 M
Cash & Short-Term Investments 41.4 M
Receivables 85.7 M
Other Current Assets 10.6 M
Non-Current Assets 1.03 B
Long-Term Investments 12.2 M
PP&E 166 M
Other Non-Current Assets 852 M
3.54 %7.34 %14.23 %72.95 %Total Assets$1.2b
Current Liabilities 116 M
Accounts Payable 5.94 M
Short-Term Debt 50.8 M
Other Current Liabilities 59.5 M
Non-Current Liabilities 292 M
Long-Term Debt 103 M
Other Non-Current Liabilities 189 M
12.45 %14.57 %25.16 %46.37 %Total Liabilities$408.4m
EFFICIENCY
Earnings Waterfall U.S. Physical Therapy, Inc.
image
Revenue 561 M
Cost Of Revenue 437 M
Gross Profit 124 M
Operating Expenses 60.7 M
Operating Income 63.2 M
Other Expenses 17.6 M
Net Income 45.6 M
600m600m500m500m400m400m300m300m200m200m100m100m00561m(437m)124m(61m)63m(18m)46mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
22.11% GROSS MARGIN
22.11%
11.28% OPERATING MARGIN
11.28%
4.72% NET MARGIN
4.72%
5.41% ROE
5.41%
2.27% ROA
2.27%
4.34% ROIC
4.34%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis U.S. Physical Therapy, Inc.
image
100m100m90m90m80m80m70m70m60m60m50m50m40m40m30m30m20m20m10m10m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 45.6 M
Depreciation & Amortization 18.7 M
Capital Expenditures -9.19 M
Stock-Based Compensation 7.82 M
Change in Working Capital 0
Others -2.53 M
Free Cash Flow 65.8 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets U.S. Physical Therapy, Inc.
image
Wall Street analysts predict an average 1-year price target for USPH of $98 , with forecasts ranging from a low of $98 to a high of $98 .
USPH Lowest Price Target Wall Street Target
98 USD 50.58%
USPH Average Price Target Wall Street Target
98 USD 50.58%
USPH Highest Price Target Wall Street Target
98 USD 50.58%
Price
Max Price Target
Min Price Target
Average Price Target
1101101051051001009595909085858080757570706565May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.50% DIVIDEND YIELD
0.45 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.801.801.601.601.401.401.201.201.001.000.800.800.600.600.400.400.200.200.000.000.150.170.230.270.320.350.410.430.440.450.150.170.20.20.230.270.350.410.430.440.150.170.20.230.30.380.410.430.440.150.600.170.680.20.830.230.930.31.150.381.380.411.580.431.700.441.750.890.002015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 15
6. Ownership
Insider Ownership U.S. Physical Therapy, Inc.
image
Sold
0-3 MONTHS
142 K USD 1
3-6 MONTHS
898 K USD 6
6-9 MONTHS
142 K USD 1
9-12 MONTHS
1.21 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
172 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
ADUS or USPH: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors? zacks.com - 6 days ago
ADUS vs. USPH: Which Stock Is the Better Value Option? Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 3 weeks ago
ADUS or USPH: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors? zacks.com - 1 month ago
U.S. Physical Therapy Announces the Acquisition of a Three-Clinic Physical Therapy Practice HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy practice with three clinic locations in Wyoming, which currently generates approximately $4.3 million in annual revenues and 23,000 in annual visits. The Company acquired a 65% interest in the acquired company with the current owners retaining a 35% owne. businesswire.com - 1 month ago
U.S. Physical Therapy, Inc. (USPH) Q4 2024 Earnings Call Transcript U.S. Physical Therapy, Inc. (NYSE:USPH ) Q4 2024 Results Conference Call February 26, 2025 9:30 AM ET Company Participants Chris Reading - Chairman and CEO Jake Martinez - Senior Vice President, Finance and Accounting Carey Hendrickson - Chief Financial Officer Eric Williams - President and COO Conference Call Participants Brian Tanquilutit - Jefferies Larry Solow - CJS Securities Jared Haase - William Blair Mike Petusky - Barrington Research Joanna Gajuk - Bank of America Operator Good day and thank you for standing by. Welcome to the U.S. Physical Therapy Fourth Quarter 2024 and Full Year Earnings Conference Call. seekingalpha.com - 1 month ago
U.S. Physical Therapy (USPH) Q4 Earnings Lag Estimates U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.65 per share, missing the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.59 per share a year ago. zacks.com - 1 month ago
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2024 Results HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three months and year ended December 31, 2024. FINANCIAL HIGHLIGHTS Year Ended December 31, 2024 versus Year Ended December 31, 2023 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $81.8 million for the year ended Dece. businesswire.com - 1 month ago
U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2024 Earnings Release and Conference Call Dates HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Wednesday, February 26, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 27, 2025. Conference Call Date: Thursday, February 27, 2025 Time: 10:. businesswire.com - 1 month ago
ADUS or USPH: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 2 months ago
U.S. Physical Therapy Announces the Acquisition of an Eight-Clinic Hand and Physical Therapy Practice HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a hand and physical therapy practice with eight clinic locations in Wyoming which currently generates approximately $6.5 million in annual revenues and 43,000 in annual visits. The Company acquired a 75% interest in the Company with the current owners retaining a 25% owner. businesswire.com - 4 months ago
ADUS vs. USPH: Which Stock Should Value Investors Buy Now? Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 5 months ago
U.S. Physical Therapy, Inc. (USPH) Q3 2024 Earnings Call Transcript U.S. Physical Therapy, Inc. (NYSE:USPH ) Q3 2024 Earnings Conference Call November 6, 2024 10:30 AM ET Company Participants Chris Reading - Chairman and CEO Carey Hendrickson - Chief Financial Officer Eric Williams - President and COO Graham Reeve - Chief Operating Officer, West Rick Binstein - Executive Vice President and General Counsel Jake Martinez - Senior Vice President, Finance and Accounting Conference Call Participants Brian Tanquilutit - Jefferies Joanna Gajuk - Bank of America Larry Solow - CJS Securities Mike Petusky - Barrington Research Operator Good day and thank you for standing by. Welcome to the U.S. Physical Therapy Third Quarter 2024 Earnings Conference Call. seekingalpha.com - 5 months ago
8. Profile Summary

U.S. Physical Therapy, Inc. USPH

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 989 M
Dividend Yield 0.50%
Description U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Contact 1300 West Sam Houston Parkway South, Houston, TX, 77042 https://www.usph.com
IPO Date May 29, 1992
Employees 4034
Officers Mr. Eric Joseph Williams President & Chief Operating Officer Mr. Chadd Pence Senior Vice President of Information Systems Mr. Graham D. Reeve M.B.A., P.T. Chief Operating Officer - West Mr. Richard S. Binstein Executive Vice President, General Counsel & Secretary Mr. Jake Martinez Senior Vice President of Finance & Accounting Mr. Jason Anderson Vice President of Human Resources Mr. Carey P. Hendrickson Chief Financial Officer Mr. Christopher J. Reading Chairman & Chief Executive Officer Ms. Jayne Fleck Pool ATC, PT, SCS Senior Vice President & Chief Compliance Officer